| Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of … K Li, B Donaldson, V Young, V Ward, C Jackson, M Baird, S Young Clinical & translational immunology 6 (10), e160, 2017 | 42 | 2017 |
| Adaptive homeostasis and the p53 isoform network S Mehta, H Campbell, CJ Drummond, K Li, K Murray, T Slatter, ... EMBO reports 22 (12), e53085, 2021 | 34 | 2021 |
| Antigen incorporated in virus-like particles is delivered to specific dendritic cell subsets that induce an effective antitumor immune response in vivo K Li, A Peers-Adams, SJ Win, S Scullion, M Wilson, VL Young, P Jennings, ... Journal of Immunotherapy 36 (1), 11-19, 2013 | 33 | 2013 |
| Conditions for the generation of cytotoxic CD4+ Th cells that enhance CD8+ CTL‐mediated tumor regression K Li, M Baird, J Yang, C Jackson, F Ronchese, S Young Clinical & Translational Immunology 5 (8), e95, 2016 | 20 | 2016 |
| Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasis K Li, K Ly, S Mehta, A Braithwaite Clinical & Translational Immunology 11 (5), e1394, 2022 | 9 | 2022 |
| Potent antietumor immunity in mice induced by vaccination with an ovine atadenovirus vector R Tang, K Li, M Wilson, GW Both, JA Taylor, SL Young Journal of immunotherapy 35 (1), 32-41, 2012 | 6 | 2012 |
| Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis AK Wiles, S Mehta, M Millier, AG Woolley, K Li, K Parker, M Kazantseva, ... Arthritis research & therapy 25 (1), 62, 2023 | 2 | 2023 |
| Combining TP53 mutation and isoform has the potential to improve clinical practice SR Das, B Delahunt, A Lasham, K Li, D Wright, C Print, T Slatter, ... Pathology, 2024 | 1 | 2024 |
| Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes? SM Hossain, K Ly, YJ Sung, A Braithwaite, K Li International journal of molecular sciences 25 (18), 10120, 2024 | | 2024 |
